Actavis, a foreign generic company, will enter the domestic market, followed after Teva and Alvogen

Another generic of a multinational brand is expected to enter the domestic market.

The company is the top U.S. generic company, Actavis. After taking over the pharmaceutical company specializing in cosmetic products, such as Botox, Allergan, last November, the company changed its company name to Allergan. The action was applied in all of its global branches except for the U.S. and Canada.

Acc...